SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

WorldFinancial

WLFI is gaining traction amid news of its application for a National Trust Bank Charter to issue the USD1 stablecoin and anticipated launch of a crypto app with real-world asset tokenization initiatives. The community is actively discussing ongoing treasury-funded token buybacks and burns, alongside strategies to acquire tokens at a discount via ALTS, though some caution against potential "pump and dump" dynamics.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is trending due to renewed geopolitical focus on Greenland's critical mineral wealth, driven by former President Trump's discussions about acquiring the island. The community is highly engaged, anticipating significant benefits for CRML's Tanbreez Rare Earth Project from potential U.S. investment or agreements aimed at securing non-Chinese supply for strategic industries. This creates strong bullish sentiment as investors eye a potential "Art of the Deal" outcome for Greenland's vast resources.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending amid intense buyout speculation, fueled by strong financial performance of its Lupkynis drug and growing anticipation for crucial updates on its AUR200 pipeline. The community is actively debating potential acquisition by major pharmaceutical companies, alongside significant frustration with management's communication regarding these strategic developments.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intense debate surrounding the former president's reported intentions regarding Greenland and Venezuela's oil resources, alongside highly contentious discussions about domestic law enforcement actions. The community is sharply polarized, with supporters applauding perceived strong economic plans and decisive leadership, while critics voice alarm over alleged authoritarianism and potentially reckless foreign policy. This deep political division directly fuels conversation around the stock, reflecting broader geopolitical and domestic tensions.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

PANDU CRYPTO is actively discussed as a Solana-based project gaining traction for its continuous development of utility, including an AI assistant app and NFT staking. There's significant excitement around its growing user base, recent platform integrations, and a belief that its consistent building positions it for future growth within the broader crypto market.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is heavily trending amid an intensifying bidding war for its assets, with Paramount Skydance reaffirming its all-cash offer despite the WBD board's repeated rejections in favor of a rival proposal. Community discussion keenly scrutinizes the financial risks and valuations of legacy media assets and spin-offs associated with each bid. This ongoing M&A saga keeps the entertainment sector captivated, fueling widespread speculation for further strategic developments.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group (GRRR) is trending as discussions heat up over its recently announced pause of the share repurchase program until mid-March, with the company citing limited share availability. This decision has sparked polarized community reactions, as some view it as a compliance-driven move ahead of major announcements, while others suspect it's a deliberate tactic to manage stock price, intensifying debate around the company's communication strategy and its tightly held float.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog ($DOG) is currently trending with its community enthusiastically asserting its position as the leading Bitcoin-native memecoin, emphasizing its fair launch and robust security on the Bitcoin blockchain. Recent bullish signals are fueling discussions that the dedicated "DOG Army" believes it's poised to lead the next wave of crypto assets, aiming to "drop the E" and outperform other tokens by leveraging Bitcoin's ecosystem.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst intensified competition in the weight loss market, notably with Amazon Pharmacy now offering branded GLP-1 medications. This, alongside ongoing regulatory scrutiny concerning compounded treatments and recent analyst concerns, fuels a sharp community debate about the company's competitive positioning. While many anticipate further declines, others view the current valuation as a compelling buying opportunity, citing HIMS's fundamental growth, international expansion, and diverse service offerings.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending due to robust December sales and strong international growth, which are bolstering confidence in its resilient membership model. The community is actively discussing the potential for a significant upside if a looming Supreme Court tariff ruling favors importers, alongside technical breakouts from recent downtrends, despite ongoing valuation debates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>JNJ agreed to drug discounts and tariff exemptions under a White House deal.</li><li>The agreement builds on its existing $55 billion U.S. manufacturing and R&amp;D plan.</li><li>New facilities add to projects already underway in North Carolina and Pennsylvania.</li></ul><p>Johnson &amp; Johnson (JNJ) said on Thursday it has reached a voluntary agreement with the U.S. government to expand access to medicines, lower drug costs for American patients, and secure exemptions from U.S. tariffs on its pharmaceutical products, while advancing its domestic manufacturing plans.</p><h2 class="st-heading-2"><strong>Drug Pricing And Tariff Exemptions</strong></h2><p>As part of the deal, JNJ will allow Americans to buy medicines at significantly discounted rates through TrumpRx.gov, a government-backed direct-to-patient platform. The company will also provide U.S. Medicaid programs access to medicines at prices comparable to those in other developed countries.</p><p>The deal grants JNJ’s pharmaceutical products exemptions from U.S. tariffs and aligns with the administration’s “most-favored-nation” pricing framework.</p><p>“Today’s agreement shows that when the public and private sectors work together towards shared goals, we can deliver real results for patients and the U.S. economy,” CEO Joaquin Duato said in a statement.&nbsp;</p><h2 class="st-heading-2"><strong>US Manufacturing Commitments</strong></h2><p>JNJ said the agreement builds on its previously announced $55 billion U.S. investment plan through early 2029, which focuses on expanding domestic manufacturing, research and development, and technology.&nbsp;</p><p>As part of the plan, the company announced two additional U.S. manufacturing facilities, including a cell therapy site in Pennsylvania and a drug product manufacturing facility in North Carolina. Construction is already underway at the company’s $2 billion biologics facility in Wilson, North Carolina, a project expected to support around 5,000 manufacturing and construction jobs.&nbsp;</p><p>Separately, JNJ has committed $2 billion over the next 10 years to a biopharmaceutical site in Holly Springs, North Carolina, which is expected to create about 120 jobs. The company said it expects to announce further U.S. investments later this year.</p><h2 class="st-heading-2"><strong>White House Drug Deals Expand</strong></h2><p>The announcement follows&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-strikes-new-drug-price-deals-with-roche-novartis-merck-and-other-pharma-giants/cLe0duBREtP">similar agreements struck last month</a> between the White House and other major drugmakers, including Amgen, Bristol Myers Squibb, Pfizer, Gilead Sciences, GSK, Merck, Novartis, Roche and Sanofi.</p><p>The deals require steep discounts through TrumpRx, most-favored-nation pricing for Medicaid, expanded U.S. manufacturing, and restrictions on stockpiling drugs to avoid tariffs.</p><h2 class="st-heading-2"><strong>How Did Stocktwits Users React?</strong></h2><p>On Stocktwits, retail sentiment was ‘bearish’ amid ‘high’ message volume.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/jnj_ss_png_1d85f7828a.webp" alt="jnj ss.png" width="967" height="142"><figcaption>JNJ sentiment and message volume as of January 8| Source: Stocktwits</figcaption></figure><p><a href="https://stocktwits.com/symbol/JNJ">JNJ’s stock</a> has risen 49% over the past 12 months.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, a Johnson & Johnson logo seen displayed on a monitor. (Photo Illustration by Valera Golovniov/SOPA Images/LightRocket via Getty Images)

J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs 

The company will also provide U.S. Medicaid programs access to medicines at prices comparable to those in other developed countries.

Equity

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know

In the closing of the recent trading day, Amgen (AMGN) stood at $330.05, denoting a -3.39% move from the preceding trading day.

Amgen (NASDAQ:AMGN) Price Target Raised to $319.00 at Truist Financial

Truist Financial increased their target price on Amgen from $318.00 to $319.00 and gave the company a "hold" rating in a research note on Thursday...

RVMD Stock Hits a Record High on Rumored Takeover Interest

Revolution Medicines shares jump nearly 29% to a record high after a WSJ report said AbbVie showed takeover interest, a claim the pharma giant later denied.

J&J's Innovative Medicine Segment in Q4: Here's What to Watch

JNJ's Innovative Medicine segment shows resilience ahead of Q4 results, with key drugs driving growth despite Stelara biosimilars and Part D headwinds.

ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies

Alumis shares jump 95% after envudeucitinib meets all endpoints in two phase III plaque psoriasis studies, showing strong skin clearance.

Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline

AMGN's $840M buyout of Dark Blue Therapeutics adds a preclinical AML degrader, bolstering its oncology pipeline.

Robeco Institutional Asset Management B.V. Has $123.48 Million Stock Position in Amgen Inc. $AMGN

Robeco Institutional Asset Management B.V. lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.5% during the third quarter, according to the company in its most recent Form...

CX Institutional Increases Stake in Amgen Inc. $AMGN

CX Institutional increased its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 9.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and...

Cerity Partners LLC Sells 6,837 Shares of Amgen Inc. $AMGN

Cerity Partners LLC reduced its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange...

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$326.10
Prev Close	$330.11
Open	$328.81
Dividend Yield	3.45%
50-Day Moving Average	$327.35
Beta	0.50
Avg. Volume	2.92M
PE Ratio	25.21

52-Week High	$346.38
52-Week Low	$261.28
Market Capitalization	$177.76B
EPS (Annual)	$7.56
Price to Book	18.26
Revenue Per Employee	$1.19M
Enterprise Value/EBITDA	N/A

AMGN
AMGEN Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMGN News

AMGNAMGEN Inc.